Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

Clinical lymphoma & myeloma

Volumn 9 Suppl 3, Issue , 2009, Pages

  Champlin, Richard ^a   de Lima, Marcos ^a   Kebriaei, Partow ^a   Rondon, Gabriela ^a   Fisher, Tobi ^a   Jabbour, Elias ^a   Cortés, Jorge E ^a   Kantarjian, Hagop ^a   Anderlini, Paolo ^a   Alousi, Amin ^a   Hosing, Chitra ^a   Shpall, Elizabeth ^a   Popat, Uday ^a   Qazilbash, Muzaffar ^a   Andersson, Borje ^a   Giralt, Sergio ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

ADULT; AGED; ALLOTRANSPLANTATION; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; DRUG ANTAGONISM; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; METHODOLOGY; MIDDLE AGED; ONCOLOGY; REMISSION; REVIEW; STEM CELL TRANSPLANTATION; TIME; TREATMENT OUTCOME;

ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; GRAFT VS LEUKEMIA EFFECT; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MEDICAL ONCOLOGY; MIDDLE AGED; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 74049104918     PISSN: None     EISSN: 19380712     Source Type: Journal    
DOI: 10.3816/clm.2009.s.021     Document Type: Review

References (56)